Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Antineoplaston Therapy in Treating Patients With High-Grade Stage II - Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01969695. IPD Sharing: NO. Countries: 1. Publications: 0.
Ibrutinib and Nivolumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
ClinicalTrials.gov study NCT02940301. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00025064. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT03652441. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
The Combination of Rad001 and Rituximab In Patients With Non-hodgkin's Lymphomas
ClinicalTrials.gov study NCT01567475. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04169932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06021678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT05097443. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Refractory or Relapsed Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01429025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00055783. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy
ClinicalTrials.gov study NCT04044222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients
ClinicalTrials.gov study NCT06665737. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00003204. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
ClinicalTrials.gov study NCT03015896. IPD Sharing: NO. Countries: 1. Publications: 0.
IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma
ClinicalTrials.gov study NCT01333605. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma
ClinicalTrials.gov study NCT01165645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.
ClinicalTrials.gov study NCT04639739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A
ClinicalTrials.gov study NCT01858922. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT04746131. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.